ANESTHESIA FOR A GERIATRIC PATIENT WITH HEART DISEASE

Slides:



Advertisements
Similar presentations
The Mystery of Surgical Clearance Shane Hull, D.O. Edmond Pulmonology.
Advertisements

Dr. Sonia Anand McMaster University
Beta Blockers In Anesthesia. Introduction Introduction.
Acquired Heart Disease
Off pump CABG has been performed for the first time 40 years ago. Although conventional CABG is considered both safe and effective, the use of CBP.
Perioperative Issues Dr John Oyston Dept of Medicine Rounds April 15 th 2008.
Jason E. Davis, MD PERI-OPERATIVE CARDIAC RISK REDUCTION, A-FIB/MI MANAGEMENT.
Ryan Hampton January  Risks and benefits of surgery  Timing of surgery  Type of Surgery  Goal is to uncover undiagnosed problems or treat prior.
CARDIAC RISK ASSESSMENT FOR NONCARDIAC SURGERY JOHN HAMATY D.O. SOUTH JERSEY HEART GROUP SJHG.ORG.
Jacobi Ambulatory Care Service Medical Consultation: An Overview Lori A. Lemberg, MD Fall 2012.
PREOPERATIVE ASSESSMENT OF THE GERIATRIC PATIENT Cheryl Hinners M.D.
Review cases 14-Apr SA is a 47 years old male who developed crushing substernal chest pain around 10 pm, he didn’t went to the hospital, in the.
Cardiovascular Pre-Operative Evaluation for Non-Cardiac Surgery Jessica Thom PGY-1.
Central Sleep Apnea Problem Based Learning Module Vidya Krishnan, and Sutapa Mukherjee for the Sleep Education for Pulmonary Fellows and Practitioners,
Focusing on the Surgical Patient with Cardiac Problems By Kate J. Morse, RN, ACNP-BC, CCRN Nursing2009, March ANCC contact hours Online:
Dean Handimulya UIEU 2005 Congestive Heart Failure Dean Handimulya, M.D.
Epidemiology of Noncardiac Surgery Dr. Mohammed Naser.
Heart disease. Congenital Ischemic Hypertensive Valvular Cardiomyopathy Pericardium Tumors.
Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2007 ACC/AHA and 2009 ESC GUIDELINES.
Perioperative Cardiovascular Evaluation for Noncardiac Surgery By :Mahmoud M Othman MD, Prof of Anesthesia & SICU, Mansoura faculty of Medicine.
Preoperative assessment
Perioperative Risk Assessment - Can You Get It Right?
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Angiography Excessive Commercialisation Complications of Angiography 1.Death 2.Myocardial Infarction Factors predisposing Unstable angina Angina at rest.
Perioperative and Consultative Medicine Pamela J. Pride MD, FHM Medical University of South Carolina 2/7/2012.
Preoperative Cardiac Evaluation Jonathan Hastie January 31, 2006.
PREOPERATIVE EVALUATION
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
Dr. S. Parthasarathy MD., DA., DNB, MD (Acu), Dip. Diab. DCA, Dip. Software statistics Ph D (physiology) Mahatma Gandhi medical college and research institute,
Perioperative Testing
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
Perioperative and Consultative Medicine Pamela J. Pride MD, FHM Medical University of South Carolina 2/7/2012.
Prepared by Dr. Mahmoud Abdel-Khalek Jan 2015 Preoperative Evaluation, Preparation and Premedication.
NYU Medical Grand Rounds Clinical Vignette Jennifer Lue, MD PGY-2 9/11/2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Lecture Title: Lecture Title: Role of anesthesiologist in pre-operative period Lecturer name: Lecturer name: Prof. Ahmed Abdulmoemn Lecture Date:
- To understand the perioperative period term. - To understand the objectives of preoprative visit. - To identify the risk factors in anesthesia. - To.
Cardio Investigations. Patients presenting with chest pain may be identified as having definite or possible angina from their history alone. Risk Factor.
3/99medslides.com1 Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Surgery ACC/AHA Task Force JACC 1996; 27: Circulation 1996;
CARDIAC DISEASE IN PREGNANCY. Physiologic Changes of Pregnancy Blood volume and cardiac output rise in pregnancy to a peak that is 150% of normal by 24.
Lecture Title: Lecture Title: Role of anesthesiologist in pre-operative period Lecturer name: Lecture Date:
Perioperative and Consultative Medicine Pamela J. Pride MD, FHM Medical University of South Carolina 2/7/2012.
Clinical Correlations The NYU Langone Online Journal of Medicine
Pre-operative Cardiovascular Evaluation: Guidelines and More Eric A. Brody MD, FACC Medical Director, NA Cardiology and Medical Services Associate Professor.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
Preoperative Cardiac Evaluation
1. Dr. Mansoor Aqil Prof. and Consultant Department Of Anaesthesia King Saud University Riyadh 2.
Risk Stratification in Unstable Angina Prospective Validation of the Braunwald Classification JAMA, January 11, 1995-Vol.273,No. 2.
1. Dr. Mansoor Aqil Associate Prof. and Consultant Department Of Anaesthesia King Saud University Riyadh 2.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Cardio-Pulmonary Pre Operative Risk Assessment Andy Shakespeare MD PGY2 Baylor Scott and White IM
Oncology Institute of Vojvodina Department of anaesthesiology and intensive care Institutski put 4, Sremska Kamenica, SERBIA
Segment 1 Perioperative Risk Assessment. Need Advice – How Low is Low Dear Consult Sages ; I need your help and guidance to provide better service to.
Indication Contraindication Preparation
Role of Anesthesiologist Peri-Operative Period. Lecture Objectives.. Students at the end of the lecture will be able to: a) Obtain a full history and.
Ed Vandenberg, MD, CMD Geriatric Section OVAMC & Section of Geriatrics
CORONARY ARTERY DISEASE
PREOPERATIVE EVALUATION in the ELDERLY Module 2 CARDIAC ASSESSMENT
Pre-anesthesia evaluation and preparation of patient
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
preoperative evaluation
FUNCTIONAL STATUS AND ASA CLASSIFICATION
Chapter 28 Management of Patients With Coronary Vascular Disorders
Dr. PJ Devereaux on behalf of POISE Investigators
Train-the-Trainer Cases
Train-the-Trainer Cases
Train-the-Trainer Cases
Presentation transcript:

ANESTHESIA FOR A GERIATRIC PATIENT WITH HEART DISEASE DR.BALAVENKAT,DR.KALYANASUNDARAM, DR.SUDARSHAN,DR.VENKATACHELLAM,DR.MAHESH

A 83-year-old, 65 kg man fell down in his yard and was diagnosed as left femoral neck fracture. The patient’s medical history includes coronary artery disease, for which he had undergone 4-vessel coronary artery bypass grafting nine years prior to this admission; hypertension, a history of stroke one year earlier; insulin-dependent diabetes and benign prostatic hypertrophy. His medications at home included Nitroglycerin 0.4 mg daily, Metoprolol 25 mg twice daily, Lisinopril 20 mg daily, Aspirin with Clopidogrel daily, Insulin injection 20 units daily, Metformin 400 mg twice daily, Finasteride 5 mg daily.

His ECG has ST depression in Lead I and aVL His ECG has ST depression in Lead I and aVL. He has Q waves in II, III and aVF. He has occasional ventricular ectopics. His chest X-ray showed cardiomegaly and pulmonary plethora. A transthoracic echocardiogram showed a decrease in ejection fraction . EF is 25-30% as compared to his baseline EF of 40-45%. His S.Creatinine is 1.8mg/dl. His random Bld sugar is 225mg/dl. His coagulation is normal. He is posted for early fracture repair and arthroplasty.

Dr.Sudarshan/Dr.Venkatachellam 1.What is the risk involved in this case? High or moderate ? 2.How do we stratify the risk in old age? Do they have an increased risk than their younger counterparts with same risk factors?

Dr.Kalyanasundaram/Dr.Balavenkat 3.Should we have to optimize him before taking him up for surgery? 4.What more information is needed? What should be done for optimization of his risk?

Dr.Sudarshan/Dr.Venkatachellam 5.How do we manage his medications? 6.What are the anesthetic concerns in this case?

Dr.Balavenkat/Dr.Venkatachellam 7.What kind of anesthetic is preferred? Regional or General? Does the type of anesthesia influence the outcomes? 8.Does the degree of monitoring influence the outcomes in this patient

Dr.Sudarshan/Dr.Kalyanasundaram 9.What postop complications can be expected in this patient? 10.How should we manage postop pain in this patient?

Panel discussion

A 83-year-old, 65 kg man fell down in his yard and was diagnosed as left femoral neck fracture. The patient’s medical history includes coronary artery disease, for which he had undergone 4-vessel coronary artery bypass grafting nine years prior to this admission; hypertension, a history of stroke one year earlier; insulin-dependent diabetes and benign prostatic hypertrophy. His medications at home included Nitroglycerin 0.4 mg daily, Metoprolol 25 mg twice daily, Lisinopril 20 mg daily, Aspirin with Clopidogrel daily, Insulin injection 20 units daily, Metformin 400 mg twice daily, Finasteride 5 mg daily. His ECG has ST depression in Lead I and aVL. He has Q waves in II, III and aVF. He has occasional ventricular ectopics. His chest X-ray showed cardiomegaly and pulmonary plethora. A transthoracic echocardiogram showed a decrease in ejection fraction (EF) of 25-30% as compared to his baseline EF of 40-45%. His S.Creatinine is 1.8mg/dl. His random Bld sugar  is 225mg/dl. His coagulation is normal. He is posted for early fracture repair and arthroplasty

ASA Grading ACC/ AHA Guidelines 2007 Goldman Risk index Lee’s modification

ASA GRADING Grade I A normal healthy patient Grade II A patient with mild systemic illness Grade III A patient with severe systemic disease, that limits function, but is not incapacitating. Grade IV A patient with severe systemic disease that is a constant threat to life. Grade V A moribund patient who is not expected to survive without the operation. Grade VI A declared brain dead patient whose organs are being removed for donor purposes.

GOLDMAN’s Risk Index Third heart sound (S3) 11    Elevated jugulovenous pressure 11    Myocardial infarction in past 6 months 10    ECG: premature arterial contractions or any rhythm other than sinus 7    ECG shows >5 premature ventricular contractions per minute 7    Age >70 years 5    Emergency procedure 4    Intra-thoracic, intra-abdominal or aortic surgery 3 Poor general status, metabolic or bedridden 3 >25 – 56% Death,22% severe complications <26 – 4% Death, 17% severe complications <6 – 0.2% Death, 0.7% severe complications

Lee’s Revised Goldman cardiac risk index Six independent predictors of major cardiac complications High risk type of surgery H/o. IHD History of HF History of cerebrovascular disease Diabetes mellitus requiring treatment with insulin Preoperative serum creatinine >2.0 mg/dL

Rate of cardiac death, nonfatal myocardial infarction, and nonfatal cardiac arrest according to the number of predictors No risk factors - 0.4 percent (95% CI 0.1-0.8 percent) One risk factor - 1.0 percent (95% CI 0.5-1.4 percent) Two risk factors - 2.4 percent (95% CI 1.3-3.5 percent) Three or more risk factors - 5.4 percent Rate of cardiac death & nonfatal MI, cardiac arrest or ventricular fibrillation, pulmonary edema, and/or complete heart block according to the No.of predictors and use nonuse or of beta blockers No risk factors - 0.4 to 1.0 percent versus <1 percent with beta blockers One to two risk factors - 2.2 to 6.6 percent versus 0.8 to 1.6 percent with beta blockers Three or more risk factors - >9 percent versus >3 percent with beta blockers

Detsky and Goldman calculators http://www.vasgbi.com/riskdetsky.htm

ACC/ AHA Guidelines 2007

INTERMEDIATE Predictors “Cardiac Predictors” MAJOR Predictors Unstable coronary syndromes Decompensated CHF Significant Arrhythmias Severe valvular disease MINOR Predictors Age Abnormal ECG Systemic hypertension Stroke INTERMEDIATE Predictors Mild angina Prior MI Compensated or prior CHF Diabetes Mellitus Renal disease

INTERMEDIATE Risk < 5% TYPE OF SURGERY Low risk < 1% Endoscopic procedures Superficial procedure Cataract Breast HIGH RISK > 5 % Emergeny major operations, especially in elderly Aortic and other major vascular procedures Peripheral vascular procedures Anticipated prolonged procedure with large fluid shift/blood loss INTERMEDIATE Risk < 5% Carotid endarterectomy Head and neck Intraperitoneal & intrathoracic Orthopedic Prostate

Functional Capacity

Step I Step 2 Step 3 Step 4 Step 5 Consider OT OT NO NO NO Perioperative surveillance & post op risk stratification and management Need for emergency non cardiac surgery Yes OT NO Step 2 Evaluate and treat as per AHA guidelines Active Cardiac condition Yes Consider OT NO Step 3 Proceed with planned surgery Low risk surgery Yes NO Step 4 Active Cardiac condition Proceed with planned surgery 1.Unstable coronary syndromes 2. Decompensated HF (NYHA functional class IV; 3. Significant arrhythmias 4. Severe valvular disease Functional capacity > or = 4 MET’s without symptoms Yes NO or Unknown Step 5

History of CAD, or CVA Pulmonary Diabetes mellitus Renal impairment Hematologic disorders STEP 5 3 or more risk factors 1 or 2 risk factors No risk factors Vascular Intermediate risk Intermediate risk Vascular Proceed with the planned surgery Consider testing if it will change management Proceed with planned surgery with HR Control or consider non invasive testing if it will change the management